Workflow
丸美品牌产品
icon
Search documents
丸美生物(603983):25H1收入端高增主品牌丸美势能向好
Hua Yuan Zheng Quan· 2025-08-27 04:14
Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Views - The company has shown strong revenue growth in the first half of 2025, with total revenue reaching 1.769 billion yuan, a year-on-year increase of 30.83% [7] - The main brand, Marubi, continues to perform well, maintaining its position as the leading domestic brand in eye care products [7] - The company is benefiting from a strategic transformation and channel adjustments, leading to a positive outlook for future growth [7] Financial Performance Summary - Revenue Forecasts: - 2023: 2,226 million yuan - 2024: 2,970 million yuan (growth of 33.44%) - 2025E: 3,832 million yuan (growth of 29.04%) - 2026E: 4,735 million yuan (growth of 23.56%) - 2027E: 5,615 million yuan (growth of 18.59%) [6] - Net Profit Forecasts: - 2023: 259 million yuan - 2024: 342 million yuan (growth of 31.69%) - 2025E: 419 million yuan (growth of 22.71%) - 2026E: 540 million yuan (growth of 28.92%) - 2027E: 669 million yuan (growth of 23.88%) [6] - Earnings Per Share (EPS): - 2023: 0.65 yuan - 2024: 0.85 yuan - 2025E: 1.05 yuan - 2026E: 1.35 yuan - 2027E: 1.67 yuan [6] - Return on Equity (ROE): - 2023: 7.75% - 2024: 10.11% - 2025E: 12.03% - 2026E: 14.94% - 2027E: 17.70% [6] Brand Performance - Marubi brand achieved revenue of 1.250 billion yuan in 25H1, a year-on-year increase of 34.36% [7] - PL brand achieved revenue of 516 million yuan in 25H1, a year-on-year increase of 23.87% [7] - The company is focusing on high-quality, minimalist makeup products and has seen significant online sales growth [7] Channel Performance - Online revenue reached 1.571 billion yuan in 25H1, a year-on-year increase of 37.85% [7] - Offline revenue was 197 million yuan, a year-on-year decrease of 7.07% [7] - The company is implementing a multi-platform strategy to enhance user engagement and sales efficiency [7]
丸美生物(603983):2025 年中报点评:收入增长靓丽,费用增加致利润增速不及预期
EBSCN· 2025-08-23 13:23
Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company achieved a revenue of 1.77 billion yuan in the first half of 2025, representing a year-on-year growth of 30.8%, while the net profit attributable to shareholders grew by only 5.2% [5] - The slower profit growth compared to revenue is attributed to increased sales expenses [9] - The company plans to distribute a cash dividend of 0.25 yuan per share, corresponding to a payout ratio of 54% for the first half of the year [5] Revenue Performance - The company's two main brands, Marubi and Lianhuo, saw revenue growth of 34% and 24% respectively, with online channel revenue increasing by 38% [6] - For the first half of 2025, Marubi brand revenue was 1.25 billion yuan, accounting for 71% of total revenue, while Lianhuo brand revenue was 520 million yuan, making up 29% [6] Financial Metrics - The gross margin for the first half of 2025 slightly decreased by 0.1 percentage points to 74.6% [7] - The operating cash flow significantly increased by 97.4% year-on-year to 120 million yuan [8] - The company’s inventory as of June 2025 increased by 35.9% year-on-year to 240 million yuan [8] Profitability and Valuation - The report projects a downward revision of the net profit forecast for 2025 to 390 million yuan, reflecting a 13% decrease from previous estimates [9] - The current stock price corresponds to a price-to-earnings (P/E) ratio of 46 for 2025 [9] Future Projections - The company is expected to achieve a revenue of 3.75 billion yuan in 2025, with a growth rate of 26.3% [10] - The projected net profit for 2025 is 393 million yuan, with a growth rate of 15.1% [10]